389 results on '"Jacob‐Nara, Juby A."'
Search Results
2. Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma
3. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
4. Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
5. Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study
6. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study
7. Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study
8. Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
9. Disease Burden and Spectrum of Symptoms that Impact Quality of Life in Pediatric Patients with Eosinophilic Esophagitis
10. Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroid (VOYAGE)
11. Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
12. Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma
13. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
14. The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma
15. Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid–Dependent Allergic and Nonallergic Asthma
16. Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps
17. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
18. Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
19. Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
20. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
21. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline
22. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
23. Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose
24. Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial
25. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies
26. Examining the Role of Type 2 Inflammation in Eosinophilic Esophagitis
27. Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
28. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
29. Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
30. Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS
31. Prevalence of NSAID-ERD Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA registry
32. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
33. Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA registry
34. Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
35. Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
36. Coexisting Allergic Rhinitis In Patients With Moderate-To-Severe Asthma Initiating Dupilumab In Real-World Clinical Practice: The RAPID Registry Study
37. The impact of functional endoscopic sinonasal surgery on oral corticosteroid use and costs over 3 years in patients with chronic rhinosinusitis with nasal polyps in US real-world practice
38. Association Of Baseline Lung Function And Likelihood Of Oral Corticosteroid Reduction In Patients With OCS-Dependent Severe Asthma
39. Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial
40. Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
41. Blood eosinophils and FeNO are prognostic and predictive biomarkers in childhood asthma
42. Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.
43. Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma.
44. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
45. Oral corticosteroid (OCS) burden and healthcare resource utilization (HCRU) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who did or did not undergo functional endoscopic sinonasal surgery (FESS) in US real-world practice
46. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE study
47. Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study
48. Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma
49. Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
50. S614 Sustained Improvement in Eosinophil Counts and HSS Scores in Patients With Eosinophilic Esophagitis Treated With Dupilumab: 52-Week Results From the LIBERTY EoE TREET Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.